Patent hemostasis and comparison of two compression devices after transradial coronary catheterization and intervention

Abstract

AimThe aim of this study was to compare two compression devices after transradial coronary catheterization and intervention. MethodsOut of 280 consecutive patients who underwent cardiac catheterization and intervention (n=74) as a part of a same-day discharge program, 140 patients were applied the TR Band (TB) compression device and 140 the Seal-One (SO) compression device. The time needed to achieve patent hemostasis, duration of compression and local complications were assessed. ResultsIn the TB group, patent hemostasis was achieved in 17.5±10.3min (min), in the SO group in 21.4±10.5min (p=NS). The duration of radial artery compression was 90.7±38.4min in the TB group and 64.0±26.5min in the SO group (p<0.001). The incidence of hematomas ≥5cm did not differ between the two groups (6.4% vs. 6.4%, p=NS), the incidence of hematomas larger than 10cm was 0.7% in the TB group and 1.4% in the SO group (p=NS). No radial artery occlusion or other local complications were found. ConclusionPostprocedural radial artery compression with TR Band and Seal-One devices is associated with early patent hemostasis and a short duration of compression. The use of the Seal-One device was related to a shorter mean compression time in this study. No radial artery occlusion at discharge, nor any other local complications occurred following the radial artery compression, except for several clinically insignificant hematomas.